Trial Profile
Impact of Dapagliflozin on Left ventricular hemodynamics and Exercise-induced Pulmonary hypertension evaluated by echocardiography in patients with type 2 diabetes; an open-label prospective randomized controlled trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2020
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Antihyperglycaemics
- Indications Hypertension in diabetes; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IDOL-EPOC
- 12 Sep 2020 Primary endpoint has been met. (RVSP during exercise)
- 12 Sep 2020 Results published in the Circulation Journal
- 04 Mar 2019 Status changed from active, no longer recruiting to completed.